Medtronic

Marizyme is Pleased to Announce the Appointment of David Barthel as CEO

Retrieved on: 
Tuesday, November 16, 2021
Mortality, Coronavirus Scientific Advisory Board (Turkey), Myocardial infarction, Director, Security (finance), CEO, MBA, Area, Technology, Insurance, Medtronic, Chronic kidney disease, Forward-looking statement, II, IP, Board, Acquisition, Incidence, CABG, Company, U.S. Securities and Exchange Commission, Vein graft failure, GLOBE, SEC, Nature, Lake Forest Graduate School of Management, Nasdaq, Patent, St. Norbert College, FDA, Patient, Marketing, Pharmaceutical industry, Management

JUPITER, Fla., Nov. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme Inc. (Marizyme or the Company) (OTCQB:MRZM), is pleased to announce the hiring of Mr. David Barthel as the Chief Executive Officer for Marizyme.

Key Points: 
  • JUPITER, Fla., Nov. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme Inc. (Marizyme or the Company) (OTCQB:MRZM), is pleased to announce the hiring of Mr. David Barthel as the Chief Executive Officer for Marizyme.
  • Mr. Barthel founded The SmartPill Corp. and led the company as CEO & President until its acquisition by medical device giant, Medtronic.
  • Mr. Barthel led his team through multiple clinical trials, manufacturing, FDA approval, commercialization and successful insurance reimbursement.
  • After the acquisition by Medtronic, Mr. Barthel joined the company as Area Vice President, GIH Southeast Division.

Balderton Capital Raises New $600m Early-stage Fund to Back Europe’s Next Wave of Breakout Tech

Retrieved on: 
Wednesday, November 17, 2021
Professional Services, Technology, Mobile, Wireless, Finance, Software, Internet, BIT, Net, Goal, Publishing, THG, Seed, General partnership, Revolut, Prodigy Finance, Zego, LSE, ComplyAdvantage, NASDAQ, Insight Partners, Platform, Initial public offering, JPMorgan Chase, Capital, Investment, Medtronic, Sophia Genetics, Policy, YOOX Net-a-Porter Group, Diversity, Sale, Partnership, BET, Inclusion, Environment, Kings Cross, Kobalt Music Group, FTSE, Reproductive health, Certification, Marketing, Balderton Capital, Private law, Microsoft, Genetics, Financial services, Renewable energy, Security (finance), Video game

Balderton Capital is a very different firm than it was 12 months ago.

Key Points: 
  • Balderton Capital is a very different firm than it was 12 months ago.
  • Our transition from Europes leading Series A investor to a multi-stage fund gives us more firepower and flexibility and helps us to uncover more hidden gems among Europes startups.
  • The launch of Fund VIII marks 21 years of seed and Series A investing at Balderton.
  • Balderton Capital is Europes leading venture firm focused exclusively on backing the best European-founded technology companies.

MedReps Reveals Medical Sales Professionals' Top Choice Employers

Retrieved on: 
Tuesday, November 16, 2021
Technology, Nursing, Human Resources, Hospitals, Professional Services, Internet, Health, Pharmaceutical, General Health, Avion, Industry, Culture, Leadership, Heart, Philosophy, COVID, Research, Medtronic, Thought, Core values, Pharmaceutical industry, the Survey, MedReps, THE SURVEY, MEDREPS

A new survey by MedReps , a career site for medical sales representatives, revealed Teleflex, CONMED and Medtronic as the top three best large employers to work for.

Key Points: 
  • A new survey by MedReps , a career site for medical sales representatives, revealed Teleflex, CONMED and Medtronic as the top three best large employers to work for.
  • The 2022 Best Places to Work in Medical Sales report polled over 2,300 MedReps community professionals to identify which medical sales companies are currently the most sought-after in the industry.
  • The survey results also identified the qualities and values most important to medical sales reps today.
  • MedReps is the leading job site in medical sales, giving members access to the most sought after medical sales jobs, pharmaceutical sales jobs and career advice.

BIOMEDevice Silicon Valley Smart Event Goes Live

Retrieved on: 
Monday, November 15, 2021
General Health, Medical Devices, Manufacturing, Health, Engineering, Health, Medtech, Software, Google Health, Therapy, Engineering, Leadership, Boston Scientific, GE Healthcare, Bigfoot Biomedical, Food, San José, Medical device, Artificiality, Research, Medtronic, Cardinal Health, Digital, Stryker, Silicon, Software engineer, Abbott, Google, Regulation of tobacco by the U.S. Food and Drug Administration, PDT Standard, Solution, Smart, Johnson & Johnson, Patient, Intuitive Surgical, Mobile phone, Nightclub, Informa Markets – Engineering, Informa Markets, INFORMA MARKETS – ENGINEERING, INFORMA MARKETS

BIOMEDevice Silicon Valley , the must-attend regional event connecting biotech engineers and cutting-edge companies organized by Informa Markets Engineering, today announced the launch of the Smart Event platform, granting attendees access to a broad range of technical and forward-looking education.

Key Points: 
  • BIOMEDevice Silicon Valley , the must-attend regional event connecting biotech engineers and cutting-edge companies organized by Informa Markets Engineering, today announced the launch of the Smart Event platform, granting attendees access to a broad range of technical and forward-looking education.
  • The 2021 edition of BIOMEDevice Silicon Valley, formerly known as BIOMEDevice San Jose, is slated to be held at the San Jose McEnery Convention Center from December 8 through 9.
  • The Smart Event extends the BIOMEDevice experience, giving exhibitors and attendees more time to make meaningful connections and research product solutions.
  • Its also the place to go for thought leadership before and after the live event, said Adrienne Zepeda, Group Event Director, BIOMEDevice Silicon Valley.

Kean Health, a Newly Launched Brand by Psomagen, Inc., Is Making At-home Testing Accessible to Improve Human Wellness

Retrieved on: 
Monday, November 15, 2021
Women, Retail, Other Science, Pharmaceutical, Men, Research, Family, Medical Devices, Online Retail, Consumer, Genetics, Department Stores, Science, Clinical Trials, Medical Supplies, General Health, Health, Specialty, Science, Inc., Genomics, Low Emission Development Strategies Global Partnership (LEDS GP), Health, Roche, Technology, Diet, Â, Overalls, Product, Multimedia, Medtronic, Samsung, Genetic testing, CAP, Sleep, Health status of Asian Americans, Dietary supplement

Psomagen Inc. , a long-standing provider of genetic testing services as a CLlA-certified/CAP-accredited laboratory, has launched a new brand of at-home wellness tests catered to consumers as Kean Health .

Key Points: 
  • Psomagen Inc. , a long-standing provider of genetic testing services as a CLlA-certified/CAP-accredited laboratory, has launched a new brand of at-home wellness tests catered to consumers as Kean Health .
  • Kean Gut provides you with a snapshot of your gut microbiome and general recommendations to help you improve your gut health.
  • Kean Gut+ provides you with personalized insights about the status of your gut microbiome and how to improve your own gut health and overall wellness.
  • By making at-home testing intuitive and accessible, our users start a lifetime journey of taking data-driven action to improve their wellness.

ThoughtSpot Introduces New Data Workspace to Transform How Analysts and Developers Utilize the Modern Data Stack

Retrieved on: 
Monday, November 15, 2021
Software, Technology, Internet, Data Management, Cloud, Daimler, Language, Software as a service, ETL, News, Nationwide Building Society, Salesforce, SQL, Starburst, Block, Hulu, Royal Bank of Canada, Organization, YAML, Multimedia, Medtronic, OpenTable, TML, Analytics, Google Sheets, App Store (iOS/iPadOS), BT, Walmart, Azure, ServiceNow, Organizational founder, Amazon Web Services, Marketing, Operationalization, HubSpot, Microsoft, Video game console, Satellite navigation device, Computer data storage

ThoughtSpot , the Modern Analytics Cloud company, today announced the new ThoughtSpot Data Workspace with advanced capabilities designed to help analysts, data engineers, and developers build and operationalize Live Analytics throughout their organization.

Key Points: 
  • ThoughtSpot , the Modern Analytics Cloud company, today announced the new ThoughtSpot Data Workspace with advanced capabilities designed to help analysts, data engineers, and developers build and operationalize Live Analytics throughout their organization.
  • The ThoughtSpot Data Workspace is specifically designed to empower these professionals to put their data to work and operate more efficiently.
  • The new ThoughtSpot Data Workspace enables analytics engineers, analysts, and developers to:
    Connect directly to their cloud platform of choice.
  • The modern data stack presents an opportunity for analysts and developers to build new data experiences for their business.

ThoughtSpot Raises New Funding at $4.2B Valuation to Fuel the Modern Analytics Cloud

Retrieved on: 
Monday, November 15, 2021
Software, Technology, Internet, Data Management, Cloud, Adoption, Software as a service, Industry, Nationwide Building Society, Starburst, Organization, Entrepreneurship, CEO, Hulu, General Catalyst, Growth, Partner (business rank), Royal Bank of Canada, Multimedia, Medtronic, API, Lightspeed Venture Partners, Snowflake, Khosla Ventures, BT, Walmart, App Store (iOS/iPadOS), Azure, Organizational founder, Amazon Web Services, Marketing, GIC, Daimler, Sapphire Ventures, OpenTable, Microsoft, Video game console, Video game, Cryptocurrency

ThoughtSpot , the Modern Analytics Cloud company, today announced that it raised a $100M Series F funding round at a new $4.2B valuation, more than doubling the companys previous valuation and bringing the companys total funding to $674M.

Key Points: 
  • ThoughtSpot , the Modern Analytics Cloud company, today announced that it raised a $100M Series F funding round at a new $4.2B valuation, more than doubling the companys previous valuation and bringing the companys total funding to $674M.
  • Since then, ThoughtSpot has grown efficiently, with more than $200M in the bank prior to this funding round.
  • In the fall of last year, ThoughtSpot launched its first SaaS offering with the introduction of the Modern Analytics Cloud, the most simple, open and programmable consumption layer for the modern data stack.
  • With these new cloud capabilities, ThoughtSpot has emerged as the preferred consumption layer for this entire new data stack.

Memic Strengthens Management Team with Key Appointments

Retrieved on: 
Monday, November 15, 2021
Robotics, Chad, Medtronic, Industry, Stryker Corporation, Leadership, R, Growth, Research, Solution, LLC, Acquisition, Mazor Robotics, TEL, Intuitive Surgical, Management

"Adding top talent to our leadership team is essential to our success," said Dvir Cohen, co-founder and chief executive officer of Memic.

Key Points: 
  • "Adding top talent to our leadership team is essential to our success," said Dvir Cohen, co-founder and chief executive officer of Memic.
  • Mr. Moffat joins Memic as executive vice president of corporate operations, bringing more than 35 years of experience in senior leadership roles in operations for medical device companies.
  • Previously, he was senior vice president of operations at MAKO Surgical Corporation and a key member of the management team who built the company and led it through the $1.7 billion acquisition by Stryker Corporation in 2013.
  • Ms. Cohen joins Memic as vice president of R&D where she brings deep experience in R&D leadership at companies with advanced medical technologies.

National Spine Health Foundation Names 2021 Innovator of the Year

Retrieved on: 
Thursday, November 11, 2021
National Center for Spinal Disorders, Burman, Neck, Spine, View, Robotics, Critical care, General manager, Education, Technology, Enabling technology, Navigation, Multimedia, Research, Medtronic, Back pain, Automotive Executive of the Year Award, Medicine, Online shopping

RESTON, Va., Nov. 11, 2021 /PRNewswire/ -- The National Spine Health Foundation (NSHF) has named Medtronic Vice President and General Manager of Enabling Technologies Linnea Burman their 2021 Innovator of the Year.

Key Points: 
  • RESTON, Va., Nov. 11, 2021 /PRNewswire/ -- The National Spine Health Foundation (NSHF) has named Medtronic Vice President and General Manager of Enabling Technologies Linnea Burman their 2021 Innovator of the Year.
  • The Innovator of the Year Award is given annually to recognize excellence in advancing spinal health care and improving lives.
  • "When it comes to driving innovation, Linnea Burman is exemplary," said Dr. Rita Roy, Chief Executive Officer, National Spine Health Foundation.
  • With a focus on education, research, and advocacy, the NSHF works diligently to improve the state of spine health in America.

Titan Medical Reports Third Quarter 2021 Financial Results

Retrieved on: 
Thursday, November 11, 2021
Biotechnology, FDA, Surgery, Medical Devices, Health, Safety, G&A, Investor relations, R, Knowledge, Work, IDE, Food, De novo, Trial of the century, SBC, IFRS, Research, Medtronic, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, TMD, Interview, TSX, Hospital, National Public Safety Commission (Japan), Nature, Webcast, Pathology, Time, OEM, Marketing, Nasdaq, Enos, Patient, FDA, Surgeon, Documentation, Medical device, Pharmaceutical industry

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of its innovative surgical technologies for robotic-assisted surgery that requires a single patient access point, today announced financial results for the three and nine months ended September 30, 2021.

Key Points: 
  • Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of its innovative surgical technologies for robotic-assisted surgery that requires a single patient access point, today announced financial results for the three and nine months ended September 30, 2021.
  • The company also demonstrated system functionality in its preclinical good laboratory practice ("GLP") studies and is awaiting the final pathology results.
  • Research and development (R&D) expenses increased to $10.6 million in the quarter compared to $2.3 million in the third quarter of 2020.
  • ET today (November 11, 2021) to discuss the companys financial results for the third quarter ended September 30, 2021, and recent business highlights.